11th Mar 2021 14:35
Frontier IP Group PLC - London-based intellectual property commercialisation firm - Portfolio company inSignals Neurotech receives EUR100,000 investment from venture capital firm Portugal Ventures through its initiative Call INNOV-ID. Notes Frontier IP holds a 33% stake in inSignals. Says the funding will be used to accelerate the development of inSignals' patented technology to aid deep brain stimulation surgery on patients with Parkinson's disease and will allow it to expand preliminary clinical trials.
"This funding from Portugal Ventures will expand the clinical studies taking place with some of the most experienced neurologists in Europe. It is also a starting point to leverage international funds to bring to market solutions that will support doctors in assessing neurological diseases in innovative ways," says inSignals Co-Founder Joao Paulo Cunha.
Current stock price: 67.40 pence
Year-to-date change: up 2.1%
By Zoe Wickens; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
Frontier Ip